A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials-Reference-Cited by-同舟云学术

A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials

Published:2020 Issue:2 Volume:16 Page:243
ISSN:0973-1482
Container-title:Journal of Cancer Research and Therapeutics
language:en
Short-container-title:J Can Res Ther

Author:

Liu Yihai,Zhai Bo,Wang Hongye,Cao Cheng,Wei Xiyi,Shen Kangjie,Shu Yimei,Wan Xiaojie,Sun Jinyu,Ren Xiaohan,Dong Yuxiang

Publisher

Medknow

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway;BMC Cancer;2024-05-21

2. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-04

3. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism;Cell Division;2024-03-26

4. Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival;Oncology;2024-02-26

5. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression;Scientific Reports;2023-10-09